Skip to content
The San Francisco

FDA panel recommends wider access to peptides despite safety concerns

FDA panel recommends wider access to peptides despite safety concerns
Photo: KTVU FOX 2 News · view original

A panel of outside experts told the U.S. Food and Drug Administration this week that it should make six types of peptides more available to the public — a recommendation that contradicts advice from the agency's own scientists.

Sources and story details